The Business Research Company
The Business Research Company’s Methylmalonic Acidemia (MMA) Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
— The Business research company
LONDON, GREATER LONDON, UNITED KINGDOM, May 13, 2025 /EINPresswire.com/ — The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights – Market Sizing & Forecasts Through 2034
The methylmalonic acidemia MMA market is experiencing robust growth, seeing a rise in value from $9.39 billion in 2024 to an anticipated $9.97 billion in 2025 at a compound annual growth rate CAGR of 6.2%. The growth in the historic period can be attributed to the increasing incidence of metabolic disorders and vitamin deficiencies, increased healthcare expenditure, rise in health consciousness, increasing prevalence of genetic disorders, and growing demand from various end-user industries.
Is the Methylmalonic Acidemia (MMA) Market Set to Witness Substantial Growth?
This upward trajectory in the MMA market is expected to continue in the following years, with projections predicting a market size of $12.50 billion in 2029, a CAGR of 5.8%. The growth in the forecast period can be attributed to increasing newborn screening programs, increased awareness among healthcare professionals, a rise in gene therapy advancements, rising investments in rare disease research, and increasing availability of specialized treatments. Major trends in the forecast period include advancements in gene editing technologies, advanced diagnostic techniques for early detection, advancements in enzyme replacement therapies, adoption of precision medicine approaches, and adoption of newborn genetic screening programs.
Get Your Free Sample Market Report:
What Drives The Methylmalonic Acidemia (MMA) Market Growth?
Among the key drivers propelling this anticipated market expansion is the increasing incidence of metabolic disorders and vitamin deficiencies. Metabolic disorders – conditions in which the body has difficulty processing certain nutrients, producing energy, or regulating chemical reactions within cells – and vitamin deficiencies are becoming increasingly common due to unhealthy diets, sedentary lifestyles, and increased stress levels. As a result, these factors are contributing to an increase in vitamin B12 deficiencies, impairing methylmalonyl-CoA metabolism, accumulating methylmalonic acid and exacerbating methylmalonic acidemia MMA.
Who Are The Key Players In The Methylmalonic Acidemia (MMA) Market?
Major players in the MMA market, such as Moderna Inc., Lonza Group Ltd., Alexion Pharmaceuticals Inc., PTC Therapeutics Inc., Ironwood Pharmaceuticals Inc., Wockhardt Limited, Spectrum Chemical Manufacturing Corp., Asklepios BioPharmaceutical Inc. AskBio, Selecta Biosciences Inc., BTG International Inc., BridgeBio Pharma Inc., VectivBio Holding AG, Supriya Lifescience Ltd., Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., AdvaCare Pharma USA LLC, LogicBio Therapeutics Inc., HemoShear Therapeutics LLC, Manus Aktteva Biopharma LLP, and Deccan Nutraceuticals Pvt. Ltd., are banking on innovative solutions like mRNA-based therapies to enhance treatment outcomes for MMA by targeting the underlying genetic causes and reducing the accumulation of toxic metabolites.
Order Your Report Now For A Swift Delivery:
How Is The Methylmalonic Acidemia (MMA) Market Segmented?
Segmenting the MMA market paints a clear picture of this evolving landscape. It’s broken down by Indication, encompassing Acidosis, represented by Metabolic Acidosis and Lactic Acidosis; Ketosis, made up of Starvation-Induced Ketosis and Diabetic Ketoacidosis; Hyperammonemia, categorised as Acute and Chronic; Hypoglycemia, either Fasting or Reactive; Hyperglycemia, either Transient or Persistent; Neutropenia, either Severe or Cyclic; and Other Indications, including Failure to Thrive, Developmental Delays, Neurological Symptoms, and Renal Dysfunction. Further segmentation presents the market through Disorder Types—Homocystinuria, Isolated Methylmalonic Acidurias, Combined methylmalonic Aciduria—and finally by Distribution Channels, namely, Hospitals, Pharmacies, and Clinics.
What Is The Regional Analysis Of Methylmalonic Acidemia (MMA) Market?
From a geographical perspective, evidence suggests that North America dominated the MMA market as the largest region in 2024. However, future projections point to Asia-Pacific as the fastest-growing region in the forecast period, a trend likely driven by increasing healthcare investment and evolving medical technologies.
Browse Through More Similar Reports By The Business Research Company:
Cardiometabolic Diseases Global Market Report 2025
Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2025
Chloromethane Global Market Report 2025
About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn:
YouTube:
Global Market Model: global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Article originally published on www.einpresswire.com as Size, Trends, And Growth Insights For Global Expansion
